scPharmaceuticals (STU:2SX) Long-Term Debt : €36.23 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is scPharmaceuticals Long-Term Debt?

scPharmaceuticals's Long-Term Debt for the quarter that ended in Mar. 2024 was €36.23 Mil.

scPharmaceuticals's quarterly Long-Term Debt declined from Sep. 2023 (€35.85 Mil) to Dec. 2023 (€35.59 Mil) but then increased from Dec. 2023 (€35.59 Mil) to Mar. 2024 (€36.23 Mil).

scPharmaceuticals's annual Long-Term Debt increased from Dec. 2021 (€6.51 Mil) to Dec. 2022 (€34.73 Mil) and increased from Dec. 2022 (€34.73 Mil) to Dec. 2023 (€35.59 Mil).

scPharmaceuticals Long-Term Debt Historical Data

The historical data trend for scPharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

scPharmaceuticals Long-Term Debt Chart

scPharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

17.02

13.86

6.51

34.73

35.59

scPharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															34.79	34.84	35.85	35.59	36.23

scPharmaceuticals (STU:2SX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

scPharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of scPharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

scPharmaceuticals (STU:2SX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » scPharmaceuticals Inc (STU:2SX) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SCPH:USA

Address

2400 District Avenue, Suite 310, Burlington, MA, USA, 01803

Website

https://www.scpharmaceuticals.com

scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

scPharmaceuticals (STU:2SX) Headlines

No Headlines